IP Library Granted Patent US 9,233,016
Granted Patent B2
US 9,233,016 · App. 13/272,116 · Granted Jan 12, 2016

Elevating stomach stimulation device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,233,016
App. No.
13/272,116
Granted
Jan 12, 2016
Kind
B2
Abstract

The medical systems, apparatuses and uses thereof for treating obesity and/or obesity-related diseases are provided which relate to devices designed to stimulate an internal surface of the stomach such as the cardia. Features of the obesity treatment devices include insertion of said devices transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The devices include flotation portions and cardia-stimulating portions, so that as the level of stomach contents rise, the devices will contact and stimulate the nerves in the cardia region of the stomach to induce satiety. The devices may have non-inflatable balls, be made of skinned foam, have ballast members such as a weighted ball or quantity of saline for orientation, and various combinations thereof.

Claims (19)

1. An implantable device configured to be placed in a stomach of a patient to elevate with increased stomach contents and stimulate the cardia of the stomach, the device comprising:

an elastic elongated member that has a three-dimensional relaxed configuration and a generally linear stressed configuration, the relaxed configuration including a flotation portion commencing at a second end of the elongated member, the flotation portion having a generally two-dimensional shape defining a plane, the relaxed configuration further including a cardia-stimulating portion terminating at a first end of the elongated member, the cardia-stimulating portion being oriented generally perpendicular to the flotation portion;

a plurality of discrete, spaced buoyant bodies individually affixed to the elongated member at spaced locations along the flotation portion, each of the buoyant bodies being hollow and sealed with a fixed amount of air or an inert gas trapped therein, each buoyant body being separately sealed from each other and from the elongated member, wherein the buoyant bodies provide buoyancy to the elongated member, and wherein each of the buoyant bodies having an inflated size that fits through the esophagus without the buoyant bodies being fully or partially deflated with respect the inflated size; and

a stimulating body affixed to the first end of the elongated member, the stimulating body having a size adapted to fit through the esophagus without collapsing, wherein the device may be inserted transorally into the stomach in its stressed configuration and permitted to resume its

three-dimensional relaxed configuration in the stomach with the cardia-stimulating portion extending toward the cardia region of the stomach, wherein the flotation portion floats on the surface of fluid within the stomach while the cardia-stimulating portion extends away from the surface of the fluid toward the cardia and wherein the buoyant bodies float on the surface of the fluid and the buoyant bodies are configured to support the elongated member on the surface of the contents of the stomach in an orientation where the stimulating body contacts the cardia as the fluid rises in the stomach.

2. The implantable device of claim 1 , wherein the buoyant bodies are hollow and sealed so as to be non-inflatable.

3. The implantable device of claim 1 , wherein the buoyant bodies are substantially spherical balloons.

4. The implantable device of claim 1 , further comprising a weight located within the buoyant bodies comprising one of the group consisting of:

a ball bearing, and

a quantity of saline.

5. The implantable device of claim 1 , wherein a plurality of buoyant bodies are evenly spaced around the flotation portion of the elongated member.

6. The implantable device of claim 1 , wherein the flotation portion generally forms a ring, and the cardia-stimulating portion extends perpendicularly upward therefrom along a central axis of the ring.

7. The implantable device of claim 1 , wherein the stimulating body is a three dimensional member having an outer surface defining a hollow interior.

8. The implantable device of claim 1 , wherein a plurality of through holes are formed in the elongated member, wherein the through holes are sized to permit the passage of solids or liquids in the stomach through the elongated member and into and out of the holes.

9. An implantable device configured to be placed in a stomach of a patient to elevate with increased stomach contents and stimulate the cardia of the stomach, the device comprising:

an elastic elongated member that has a three-dimensional relaxed configuration and a generally linear stressed configuration, the relaxed configuration including a flotation portion commencing at a second end of the elongated member, the flotation portion having a generally two-dimensional shape defining a plane, the relaxed configuration further including a cardia-stimulating portion terminating at a first end of the elongated member, the cardia-stimulating portion being oriented generally perpendicular to the flotation portion;

a plurality of spaced buoyant bodies affixed to the elongated member at spaced locations along the flotation portion, the buoyant bodies being hollow and sealed with air or an inert gas trapped therein, wherein the buoyant bodies provide buoyancy to the elongated member, and

wherein each of the buoyant bodies having an inflated size that fits through the esophagus without the buoyant bodies being fully or partially deflated with respect the inflated size; and

a stimulating body affixed to the first end of the elongated member, the stimulating body having a size adapted to fit through the esophagus without collapsing, wherein the device may be inserted transorally into the stomach in its stressed configuration and permitted to resume its three-dimensional relaxed configuration in the stomach with the cardia-stimulating portion extending toward the cardia region of the stomach, wherein the flotation portion floats on the surface of fluid within the stomach while the cardia-stimulating portion extends away from the surface of the fluid toward the cardia and wherein the buoyant bodies float on the surface of the fluid and the buoyant bodies are configured to support the elongated member on the surface of the contents of the stomach in an orientation where the stimulating body contacts the cardia as the fluid rises in the stomach, wherein a plurality of through holes are formed in the elongated member, and the through holes are sized to permit the passage of solids or liquids in the stomach into and out of the holes.

Assignments (15)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2023
From: APOLLO ENDOSURGERY US, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 066128/0655 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2023
From: APOLLO ENDOSURGERY, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 066128/0812 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 5, 2023
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; LPATH THERAPEUTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 063264/0046 →
RELEASE OF SECURITY INTEREST Recorded Dec 30, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD.)
To: APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; APOLLO ENDOSURGERY, INC.; LPATH THERAPEUTICS INC.
Reel/Frame 058599/0297 →
SECURITY INTEREST Recorded Dec 23, 2021
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC. (F/K/A LPATH, INC.)
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058980/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 15, 2019
From: APOLLO ENDOSURGERY US, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 048885/0687 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0343 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0328 →
CHANGE OF NAME Recorded Mar 27, 2017
From: APOLLO ENDOSURGERY, INC.
To: APOLLO ENDOSURGERY US, INC.
Reel/Frame 042106/0912 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 30, 2016
From: APOLLO ENDOSURGERY US, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 041224/0821 →
TERMINATION OF PATENT SECURITY INTEREST (RECORDED ON 12/3/13 AT REEL/FRAME 031756/0729 AND ON 1/2/14 AT REEL/FRAME 031910/0460) Recorded Mar 2, 2015
From: OXFORD FINANCE LLC, AS AGENT
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 035120/0740 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 2, 2015
From: APOLLO ENDOSURGERY, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 035120/0843 →
SECURITY AGREEMENT Recorded Dec 3, 2013
From: APOLLO ENDOSURGERY, INC.
To: OXFORD FINANCE LLC, AS AGENT
Reel/Frame 031756/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2013
From: ALLERGAN, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 031747/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2011
From: BABKES, MITCHELL H.
To: ALLERGAN, INC.
Reel/Frame 027225/0090 →